SCOPE 365 | Home of the Clinical Research Resources

Home About Clinical Research News Insights Podcasts Videos SCOPE Events

SCOPE 365 Solve - Help Solve a Real Clinical Research Challenge

SCOPE 365 and TransCelerate Biopharma are calling for practical solutions that automate clinical data acquisition configuration using USDM digital protocols. Submit your abstract, showcase your innovation to leaders across the clinical research community, and help shape the future of study startup. Finalists will be recognized at SCOPE Europe this October.

Learn More & Submit Your Abstract »

Latest In Clinical Trials

Clinical Trial Protocol Complexity Is a Measurable Risk

Insights from SCOPE | Protocol complexity affects far more than study design. It shapes patient burden, site capacity, enrollment, retention, timelines, and cost. Learn how measuring complexity earlier can help teams identify operational risks, evaluate tradeoffs, and build more executable clinical trials. more...

August 18, 2026
DIOSynVax Advances Broadly Protective Vaccine Platform with Phase 1 Proof of Concept

Clinical Research News | Digital Immune-Optimized Synthetic vaccines (DIOSynVax) is betting that the future of vaccination lies not in chasing individual viral variants, but in designing broadly protective vaccines that target entire virus families. The University of Cambridge spinout is using artificial intelligence (AI), genomics, synthetic biology, and immunology to create vaccine antigens that could be delivered through a range of existing vaccine platforms, with early clinical data supporting the concept. more...

August 18, 2026
Management of Co-Occurring Conditions of Down Syndrome Becoming More Personalized

Clinical Research News | Medical conditions vary widely in presentation, progression, and treatment response, with Down syndrome standing out as one of the most variable of all. The genetic occurrence, caused by an extra copy of chromosome 21, is widely considered one of the most heterogenous conditions, with highly variable clinical presentation from person to person. more...

August 13, 2026
Why Patient Availability Is Not the Same as Patient Recruitability

Insights from SCOPE | Identifying eligible patients is only the beginning. Successful recruitment also depends on trust, access, provider engagement, study burden, and caregiver support. Learn why feasibility planning must look beyond patient availability to understand who can realistically participate. more...

August 13, 2026
Blood Biomarker Panel May Enable Earlier ALS Prevention Trials

Clinical Research News | Investigators at the University of Miami Miller School of Medicine reported that a 19-protein blood biomarker panel, which includes neurofilament light chain (NfL), accurately predicted the transition from presymptomatic disease to clinical amyotrophic lateral sclerosis (ALS), known as phenoconversion, across timeframes ranging from six months to five years. more...

August 12, 2026
Designing Better Clinical Trials Starts With Better Operations

Insights from SCOPE | The strongest clinical trials are designed for execution from the very beginning. Discover why integrating operational expertise into protocol development can improve recruitment, reduce site burden, strengthen feasibility, and create more scalable clinical studies. more...

August 11, 2026